Convolutional Neural Networks for MRI-Based Brain Tumor Segmentation: A Comparative Analysis of State-of-the-Art Segmentation Networks
Turkish Journal of Forecasting · 2022
DOI: 10.34110/forecasting.1190289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Forecasting, 2022. Verfasst von Ahmet Furkan BAYRAM und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
The prevalence of brain tumor is quite high. Brain tumor causes critical diseases. Also, brain tumor causes a variety of symptoms in most people. This study aims to segmentation of the tumor in the brain. For this purpose, state-of-art architectures, such as UNet, Attention UNet, Residual UNet, Attention Residual UNet, Residual UNet++, Inception UNet, LinkNet, and SegNet were used for segmentation. 592 magnetic resonance (MR) images were utilized in the training and testing of segmentation architectures. In the comparative analysis, Attention UNet achieved the best predictive performance with a 0.886 dice score, 0.795 IoU score, 0.881 sensitivity, 0.993 specificity, 0.891 precision, and 0.986 accuracy.
Zitieren
APA
BAYRAM, A. F., GURKAN, C., BUDAK, A., & KARATAŞ, H. (2022). Convolutional Neural Networks for MRI-Based Brain Tumor Segmentation: A Comparative Analysis of State-of-the-Art Segmentation Networks. Turkish Journal of Forecasting. https://doi.org/10.34110/forecasting.1190289
Vancouver
BAYRAM AF, GURKAN C, BUDAK A, KARATAŞ H. Convolutional Neural Networks for MRI-Based Brain Tumor Segmentation: A Comparative Analysis of State-of-the-Art Segmentation Networks. Turkish Journal of Forecasting. 2022. doi:10.34110/forecasting.1190289
BibTeX
@article{BAYRAM2022,
author = {BAYRAM, Ahmet Furkan and GURKAN, Caglar and BUDAK, Abdulkadir and KARATAŞ, Hakan},
title = {Convolutional Neural Networks for MRI-Based Brain Tumor Segmentation: A Comparative Analysis of State-of-the-Art Segmentation Networks},
journal = {Turkish Journal of Forecasting},
year = {2022},
doi = {10.34110/forecasting.1190289}
}
EUVIMED